The association between higher maternal pre-pregnancy body mass index and increased birth weight, adiposity and inflammation in the newborn

Pediatric Obesity

Volumn 13, Issue 1, 2018, Pages 46-53

  McCloskey, K ^a,b,c   Ponsonby, A L ^a,c   Collier, F ^b,e   Allen, K ^a,c   Tang, M L K ^a,c   Carlin, J B ^a,c   Saffery, R ^a,c   Skilton, M R ^f   Cheung, M ^a,c   Ranganathan, S ^a,c   Dwyer, T ^a,c   Burgner, D ^a,c,d   Vuillermin, P ^a,b,e  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b BARWON HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e DEAKIN UNIVERSITY   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Neonatal; obesity; offspring; pregnancy

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; LIPID;

ADULT; ANTHROPOMETRY; AORTIC INTIMA; ARTERIAL WALL THICKNESS; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY MASS; COMORBIDITY; ECHOGRAPHY; FEMALE; GESTATION PERIOD; HUMAN; INFANT; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MALE; NEWBORN; OBESITY; PRIORITY JOURNAL; SKINFOLD THICKNESS; UMBILICAL CORD; UMBILICAL CORD BLOOD; BLOOD; FETUS BLOOD; GESTATIONAL AGE; METABOLISM; MOTHER; PREGNANCY; RISK FACTOR;

ADIPOSITY; ADULT; BIRTH WEIGHT; BODY MASS INDEX; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; LIPIDS; MALE; MOTHERS; PREGNANCY; RISK FACTORS; SKINFOLD THICKNESS;

EID: 84990928821     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/ijpo.12187     Document Type: Article

References (30)

1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2013; 385: 117–171.
2. Wilson RM, Messaoudi I. The impact of maternal obesity during pregnancy on offspring immunity. Mol Cell Endocrinol 2015; 418: 134–142.
3. Boney CM, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290–e296.
4. Marchi J, et al. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev 2015; 16: 621–638.
5. Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010; 106: 56–61.
6. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr 2006; 26: 271–291.
7. Hwang HS, et al. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2007; 98: 105–109.
8. Schmatz M, et al. Maternal obesity: the interplay between inflammation, mother and fetus. J Perinatol 2010; 30: 441–446.
9. Murabayashi N, et al. Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. Eur J Obstet Gynecol Reprod Biol 2013; 169: 39–44.
10. Ding Y, et al. DNA hypomethylation of inflammation-associated genes in adipose tissue of female mice after multigenerational high fat diet feeding. Int J Obes (Lond) 2014; 38: 198–204.
11. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007; 49: 2129–2138.
12. Segura J, Ruilope LM. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial. Lancet 2009; 374: 26 author reply 26-7.
13. Schipper HS, et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. Diabetologia 2012; 55: 2800–2810.
14. Shine B, et al. Serum C-reactive protein in normal and infected neonates. Clin Chim Acta 1985; 148: 97–103.
15. Martinez-Lopez DG, et al. Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitis. Pediatr Res 2014; 75: 67–74.
16. Vuillermin P, et al. Cohort profile: The Barwon Infant Study. Int J Epidemiol 2015; 44: 1148–1160.
17. Organisation, W.H. Obesity and overweight. January 2015 [cited September 2015; Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
18. Pink, B, Technical Paper: Socio-economic Indexes for Areas (SEIFA), A.B.o. Statistics, Editor. 2011.
19. Group, W.H.O.M.G.R.S. Reliability of anthropometric measurements in the WHO Multicentre Growth Reference Study. Acta Paediatr Suppl 2006; 450: 38–46.
20. Tikellis G, et al. Maternal and infant factors associated with neonatal adiposity: results from the Tasmanian Infant Health Survey (TIHS). Int J Obes (Lond) 2012; 36: 496–504.
21. Dobbins TA, et al. Australian national birthweight percentiles by sex and gestational age, 1998-2007. Med J Aust 2012; 197: 291–294.
22. Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods 2010; 15: 309–334.
23. Hicks RTD. Causal mediation analysis. Stata J 2011; 11: 605–611.
24. Hull HR, et al. Impact of maternal body mass index on neonate birthweight and body composition. Am J Obstet Gynecol 2008; 198: 416 e1-6.
25. Sewell MF, et al. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 2006; 195: 1100–1103.
26. Retnakaran R, et al. Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus. CMAJ 2012; 184: 1353–1360.
27. Westermeier F, et al. Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation. Biomed Res Int 2014; 2014: 917672.
28. Fisk NM, Fysh JW. C-reactive protein (CRP) as a marker for infection. Acta Obstet Gynecol Scand 1988; 67: 189.
29. McIntyre HD, et al. Overweight and obesity in Australian mothers: epidemic or endemic? Med J Aust 2012; 196: 184–188.
30. Emsley R, Dunn G, White IR. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res 2010; 19: 237–270.